A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
Publication year
2018Source
Clinical Pharmacokinetics, 57, 11, (2018), pp. 1421-1433ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Pharmacology-Toxicology
Clinical Pharmacy
IMM - Institute for Molecules and Materials
Journal title
Clinical Pharmacokinetics
Volume
vol. 57
Issue
iss. 11
Page start
p. 1421
Page end
p. 1433
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 11: Renal disorders RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health SciencesThis item appears in the following Collection(s)
- Academic publications [227244]
- Electronic publications [108520]
- Faculty of Medical Sciences [86731]
- Faculty of Science [34012]
- Open Access publications [77772]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.